CYCN - CIK 0001755237
Cyclerion Therapeutics, Inc. (CYCN) reported net income of -$3.53M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$3.53M | -15.4% |
| FY 2024 | -$3.06M | +41.9% |
| FY 2023 | -$5.26M | +88.1% |
| FY 2022 | -$44.08M | +14.7% |
| FY 2021 | -$51.65M | +33.6% |
| FY 2020 | -$77.80M | +36.8% |
| FY 2019 | -$123.01M | -6.7% |
| FY 2018 | -$115.25M | - |
Cyclerion Therapeutics, Inc. (CYCN) reported net income of -$3.53M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2018 and fiscal 2025, Cyclerion Therapeutics, Inc.'s net income grew from -$115.25M to -$3.53M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.